NT_1170x120_1-11-18

Carmen Churcott

2018 Retail Forecast: Learning to Adapt

2018 Retail Forecast: Learning to Adapt

What will the second year of the Trump administration look like? Is the demise of the Affordable Care Act imminent? Will pharmacists get the greater role in health care they have long sought? These are among the questions top chain drug industry executives are pondering as they look to 2018. With spiraling health care costs and

Pharmasave in expansion mode

Pharmasave in expansion mode

LANGLEY, British Columbia — Pharmasave Drugs celebrated a major milestone last month with the opening of its 600th drug store. The store network spans nine provinces of Canada and will be supplemented by many more outlets now in the pipeline for 2017, according to Carmen Churcott, chief executive officer of Pharmasave National. “Since 1981, when

Pharmasave reaches the 600-store mark

Pharmasave reaches the 600-store mark

LANGLEY, British Columbia — Continuing its steady expansion, Pharmasave Drugs National Ltd. has reached a milestone with the opening of its 600th store. One of Canada’s largest pharmacy operations, Pharmasave has drug stores across nine provinces and said that “many more are in the pipeline for 2017.” Over the past two years, the Langley, British

2017 Retail Forecast: Times Are A Changin’

2017 Retail Forecast: Times Are A Changin’

“The times they are a changin’,” Nobel laureate Bob Dylan sang in 1964. It’s as true now as it was 53 years ago, especially for the chain drug industry. With the incoming administration of Donald Trump, all bets are off with health care. The Affordable Care Act appears set for demise, but no one in

Neighbourhood Pharmacies elects board at annual conference

QUEBEC CITY, Quebec — The Neighbourhood Pharmacy Association of Canada, the nation’s chain drug store trade group, announced its board of directors for the coming year at its 2015 annual conference this week. Elected to the Neighbourhood Pharmacies board were Carmen Churcott, chief executive officer of Pharmasave Drugs (National), a new member to the board; Russell Cohen, executive vice president of